✦ LIBER ✦

946 PK-PD MODELING OF VIRAL KINETICS DURING TREATMENT WITH DEBIO-025 PLUS PEGYLATED INTERFERON ALPHA-2A IN TREATMENT-NAIVE HCV PATIENTS

✍ Scribed by E. Herrmann; A. Käfer; R. Flisiak; V. Nicolas-Métral; S. Zeuzem; R. Crabbe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

143 EFFICACY AND SAFETY OF INCREASING DO

✍ R. Flisiak; S.V. Feinman; M. Jablkowski; A. Horban; W. Kryczka; W. Halota; J.E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A prospective study of T- and B-lymphocy

✍ B. Soldevila; N. Alonso; M. J. Martínez-Arconada; R. M. Morillas; R. Planas; A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB